Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Gut Liver. 2018 Mar 15;12(2):119-124. doi: 10.5009/gnl17095.
Endoscopic submucosal dissection (ESD) is becoming the main procedure for the resection of early gastric cancer (EGC). The absolute indications for treating EGC with endoscopic resection were established by the Japanese Gastric Cancer Association and have been generally accepted. However, the absolute indications for treating EGC are rather strict, and expanded indications have been developed. Many studies have reported favorable long-term outcomes for patients who received curative resection for the expanded indication. ESD preserves the stomach, thereby improving patients' quality of life compared to surgery; however, a generally higher incidence of metachronous gastric cancer has been reported after ESD for EGC. Therefore, clinicians must pay careful attention during surveillance endoscopy, even after a curative ESD.
内镜黏膜下剥离术(ESD)已成为治疗早期胃癌(EGC)的主要方法。日本胃癌协会已确立了内镜下切除 EGC 的绝对适应证,并被普遍接受。然而,EGC 的绝对适应证相当严格,因此扩大了适应证。许多研究报告称,对扩大适应证的患者进行根治性切除可获得良好的长期结果。ESD 保留了胃,与手术相比,提高了患者的生活质量;然而,有研究报告称,EGC 行 ESD 后,胃癌的异时性发生率通常较高。因此,即使在 ESD 根治性治疗后,临床医生在随访内镜检查时也必须小心谨慎。